title: The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation.
abstract: The renal diseases most frequently associated with myeloma include amyloidosis, monoclonal immunoglobulin deposition disease, and cast nephropathy. Less frequently reported is light chain proximal tubulopathy, a disease characterized by κ-restricted crystal deposits in the proximal tubule cytoplasm. Light chain proximal tubulopathy without crystal deposition is only loosely related to the typical light chain proximal tubulopathy, and little is known about this entity. A search was performed of the 10 081 native kidney biopsy samples processed by our laboratory over the past 2 years for cases that had light chain restriction limited to the proximal tubule cytoplasm. A total of 10 cases of light chain proximal tubulopathy without crystal deposition were found representing 3.1% of light chain-related diseases. Nine of these 10 showed λ-light chain restriction. Only three cases of light chain proximal tubulopathy with crystals were found accounting for 0.9% of light chain-related diseases. Two of these three were κ subtype. Plasma cell dyscrasia was unsuspected in seven of the 10 patients with light chain proximal tubulopathy without crystals at the time of renal biopsy. After the biopsy was reported, follow-up was available on 9/10 patients with 9/9 showing a plasma cell dyscrasia including 8/9 with multiple myeloma. We found that light chain proximal tubulopathy without crystal formation, despite being rarely described in the literature, is over three times more common than light chain proximal tubulopathy with crystal formation in our series. And given that it is often associated with previously unrecognized myeloma, it is a critically important diagnosis.
authors.affiliation: Nephropathology Associates, Little Rock, AR 72211, USA. Chris.larsen@nephropath.com
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Larsen
authors.forename: Jane M
authors.initials: JM
authors.lastname: Bell
authors.forename: Alexis A
authors.initials: AA
authors.lastname: Harris
authors.forename: Nidia C
authors.initials: NC
authors.lastname: Messias
authors.forename: Yihan H
authors.initials: YH
authors.lastname: Wang
authors.forename: Patrick D
authors.initials: PD
authors.lastname: Walker
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001131:Arkansas; D001706:Biopsy; D003460:Crystallization; D003593:Cytoplasm / Q000276:immunology; D005260:Female; D006801:Humans; D007145:Immunoglobulin kappa-Chains / Q000032:analysis*; D007146:Immunoglobulin lambda-Chains / Q000032:analysis*; D007674:Kidney Diseases / Q000276:immunology* / Q000473:pathology; D007687:Kidney Tubules, Proximal / Q000276:immunology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000276:immunology* / Q000473:pathology; D010265:Paraproteinemias / Q000276:immunology* / Q000473:pathology
chemical_list: D007145:Immunoglobulin kappa-Chains; D007146:Immunoglobulin lambda-Chains